Track Glow Lifetech's EBIT ($-400K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Glow Lifetech (GLWLF) currently reports a EBIT of $-400K as of June 2026. That compares with $-1.6M in the prior-year period — up 74.2% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Glow Lifetech's EBIT history and peer comparisons.
Glow Lifetech's EBIT increased from $-1.6M to $-400K — a 74.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Glow Lifetech's EBIT of $-400K is lower than the Healthcare sector average of $22B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Glow Lifetech reported $-400K in EBIT as of June 2026. That compares with $-1.6M in the prior-year period — up 74.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-400K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Glow Lifetech, and consider following GLWLF for alerts when major investors trade the stock.